111 related articles for article (PubMed ID: 17325881)
1. Can a positive positron emission tomography scan be positive news?
Wooldridge JE
Leuk Lymphoma; 2007 Feb; 48(2):227-8. PubMed ID: 17325881
[No Abstract] [Full Text] [Related]
2. Importance of [18F]fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma.
Baudard M; Comte F; Conge AM; Mariano-Goulart D; Klein B; Rossi JF
Leuk Lymphoma; 2007 Feb; 48(2):381-8. PubMed ID: 17325900
[TBL] [Abstract][Full Text] [Related]
3. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
4. Enormous bilateral adrenal uptake of F-18 FDG caused by non-Hodgkin's lymphoma.
Brink I; Schneider B; Hoegerle S
Clin Nucl Med; 2002 Oct; 27(10):739-40. PubMed ID: 12352123
[No Abstract] [Full Text] [Related]
5. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
[TBL] [Abstract][Full Text] [Related]
6. PET for follicular lymphoma: a work in progress!
Wirth A
Leuk Lymphoma; 2007 Aug; 48(8):1463-4. PubMed ID: 17701573
[No Abstract] [Full Text] [Related]
7. Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.
Bishu S; Quigley JM; Bishu SR; Olsasky SM; Stem RA; Shostrom VK; Holdeman KP; Paknikar S; Armitage JO; Hankins JH
Leuk Lymphoma; 2007 Aug; 48(8):1548-55. PubMed ID: 17701586
[TBL] [Abstract][Full Text] [Related]
8. Hibernoma as an incidental finding on (18)F-FDG-PET/CT in lymphoma patient follow-up.
Navarro-Pelayo MM; Rodríguez-Fernández A; Ramírez-Navarro Á; Martín-Castro A; Gómez-Río M; Llamas-Elvira JM
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):53-5. PubMed ID: 25982593
[No Abstract] [Full Text] [Related]
9. End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.
Pyo J; Won Kim K; Jacene HA; Sakellis CG; Brown JR; Van den Abbeele AD
Clin Cancer Res; 2013 Dec; 19(23):6566-77. PubMed ID: 24052020
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUV
Annunziata S; Cuccaro A; Tisi MC; Hohaus S; Rufini V
Ann Nucl Med; 2018 Jun; 32(5):372-377. PubMed ID: 29464479
[TBL] [Abstract][Full Text] [Related]
11. Imaging follicular lymphoma using positron emission tomography with [(18)F]fluorodeoxyglucose: to what purpose?
Barrington SF; Mikhaeel NG
J Clin Oncol; 2012 Dec; 30(35):4285-7. PubMed ID: 23109690
[No Abstract] [Full Text] [Related]
12. Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET.
Kasper B; Egerer G; Gronkowski M; Haufe S; Lehnert T; Eisenhut M; Mechtersheimer G; Ho AD; Haberkorn U
Leuk Lymphoma; 2007 Apr; 48(4):746-53. PubMed ID: 17454633
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
Yáñez R; Barrios Y; Ruiz E; Cabrera R; Díaz-Espada F
J Immunother; 2008 Apr; 31(3):310-2. PubMed ID: 18317357
[TBL] [Abstract][Full Text] [Related]
14. Massive Pelvic Lymphadenopathy Due to Recurrent Non-Hodgkin Lymphoma Incidentally Revealed on a 99mTc-MDP Bone Scintigraphy.
Huang J; Xie P
Clin Nucl Med; 2016 Jun; 41(6):502-3. PubMed ID: 26828142
[TBL] [Abstract][Full Text] [Related]
15. Imaging in follicular NHL.
Hofman MS; Hicks RJ
Best Pract Res Clin Haematol; 2011 Jun; 24(2):165-77. PubMed ID: 21658616
[TBL] [Abstract][Full Text] [Related]
16. Non-transplant-related treatment options in follicular lymphoma.
Freedman AS
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):53-8. PubMed ID: 16399586
[No Abstract] [Full Text] [Related]
17. [The role of PET imaging in patients with lymphoma].
Klaeser B; Krause T
Ther Umsch; 2010 Oct; 67(10):505-10. PubMed ID: 20886456
[TBL] [Abstract][Full Text] [Related]
18. Histological transformation of follicular lymphoma after treatment: a case evaluated with PET/CT.
Mena LM; Setoain X; Abrisqueta P; Rodríguez S; López-Guillermo A; Fuster D; Lafuente S; Fuertes S; Rubí S; Pons F
Clin Nucl Med; 2009 Nov; 34(11):793-4. PubMed ID: 19851178
[No Abstract] [Full Text] [Related]
19. Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
Bentur OS; Gurion R; Gafter-Gvili A; Gatt M; Shvidel L; Horowitz NA; Ram R; Herishanu Y; Sarid N; Paltiel O; Ganzel C; Kreiniz N; Dally N; Gutwein O; Raanani P; Avivi I; Perry C
Leuk Lymphoma; 2018 May; 59(5):1163-1171. PubMed ID: 28901817
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
Luminari S; Galimberti S; Versari A; Biasoli I; Anastasia A; Rusconi C; Ferrari A; Petrini M; Manni M; Federico M
Haematologica; 2016 Feb; 101(2):e66-8. PubMed ID: 26471485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
